Photocontact dermatitis [berloque dermatitis]

L12_PHOTOCONTDERMAT

phototoxic dermatitis: a form of allergic contact dermatitis in which the allergen must be activated by light to sensitize the allergic response, and to cause a rash or other systemic effects on subsequent exposure. The second and subsequent exposures produce photoallergic skin conditions which are often eczematous. In rare cases the victims die.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L56.2 Cause of death: ICD-10 — L56.2 2 out of 7 registries used, show all original rules.	54
4. Check minimum number of events None	54
5. Include endpoints None	54
6. Filter based on genotype QC (FinnGen only)	51

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L56
Name in latin: Photodermatitis ex contactu

NAME	L12_PHOTOCONTDERMAT
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L562
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L562
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Photocontact dermatitis [berloque dermatitis] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	381	248	133
Only index persons	345	228	117
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	-	52.24	47.31
Only index persons	51.85	53.39	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	51	34	17
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	52.77	55.58	47.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L56.2

ICD-10 Finland

Photocontact dermatitis [berloque dermatitis]

+∞

77.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

142

2.24

2.13

4.5

2.6

47.75

53.55

u/l

0.55

133

(40760892) CBC W Ordered Manual Differential panel - Blood

203

2.08

1.82

9.1

6.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

294

2.18

1.75

6.1

4.6

—

(3026008) Bacteria identified in Urine by Culture

127

2.07

1.70

4.1

2.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3.82

1.65

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

112

2.07

1.63

6.0

3.9

0.00

estimate

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

167

1.93

1.50

5.0

3.7

19.92

27.01

ng/l

0.77

(40761536) Microorganisms panel - Urine sediment

2.62

1.44

2.9

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.80

1.41

1.7

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

286

1.93

1.39

6.9

4.4

—

32.56

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.68

1.34

4.3

5.2

135.67

121.83

g/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2.50

1.33

4.5

4.9

6.55

5.83

kpa

—

(3020682) Albumin/Creatinine [Ratio] in Urine

120

1.90

1.32

4.9

3.9

1.82

9.22

mg/mmol

1.87

(40758558) Short blood count panel - Blood

115

1.85

1.19

7.3

6.8

—

(1002224) Polysomnography panel

2.65

1.18

1.0

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

2.44

1.15

4.7

3.2

4.56

4.36

kpa

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

108

1.84

1.14

3.9

2.0

3.71

3.20

mg/l

0.24

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.52

1.11

4.8

5.1

27.70

24.91

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.05

1.07

2.7

1.6

—

(3023368) Bacteria identified in Blood by Culture

111

1.78

1.04

4.5

4.0

—

(3000494) Fungus identified in Specimen by Culture

1.96

0.95

3.0

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.91

0.89

2.9

2.2

0.19

0.21

g/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

217

1.60

0.89

7.3

5.5

0.00

estimate

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.87

0.87

3.9

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.84

0.86

2.0

2.5

12.58

13.25

umol/l

0.12

(3018418) pH of Serum or Plasma

127

1.63

0.82

2.1

4.4

7.38

7.40

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.87

0.81

2.2

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.72

0.81

2.5

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

221

1.55

0.80

5.7

3.9

0.00

estimate

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.82

0.78

2.1

2.6

2.36

2.48

g/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.69

0.76

2.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

447

2.04

0.75

28.0

14.2

16.20

20.61

mg/l

0.62

344

(3009261) Glucose [Presence] in Urine by Test strip

224

1.52

0.73

5.7

3.9

0.00

estimate

—

(3000492) Spirometry study

1.81

0.73

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

186

1.52

0.73

1.8

1.9

—

(3012516) Albumin [Mass/volume] in Urine

113

1.59

0.72

3.2

3.4

12.03

67.45

mg/l

1.60

(3019060) Gas panel - Arterial blood

1.80

0.65

4.4

5.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.70

0.65

3.9

9.3

104.00

102.96

mmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.70

0.65

2.9

1.6

—

(3008898) HLA-B27 [Presence]

0.00

0.61

0.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

202

1.44

0.59

4.7

2.7

77.00

89.83

ug/l

0.25

181

(40761535) Cells panel - Urine sediment

1.75

0.59

5.5

3.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.75

0.59

1.7

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

155

1.46

0.58

4.9

3.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

155

1.46

0.58

4.6

3.3

25.10

26.47

u/l

0.28

146

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

165

1.45

0.57

6.7

4.0

—

(3003694) ABO and Rh group [Type] in Blood

119

1.49

0.57

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

175

1.43

0.56

4.0

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.56

0.53

2.7

3.5

—

(3042936) Bacteria identified in Isolate by Culture

1.58

0.51

2.6

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.54

0.50

1.6

1.4

—

(3000991) Gas panel - Venous blood

1.62

0.43

5.4

9.9

—

(4035726) Immunohistochemistry procedure

1.57

0.42

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.47

0.42

1.4

2.7

2.43

2.45

mmol/l

0.41

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.42

0.0

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.2

—

(4200892) Spirometry reversibility

1.47

0.40

1.0

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

194

1.32

0.39

27.3

11.1

1.23

1.21

inr

—

(3013707) Erythrocyte sedimentation rate by Westergren method

334

1.34

0.38

7.7

4.5

11.32

10.84

mm/h

0.09

308

(3024561) Albumin [Mass/volume] in Serum or Plasma

196

1.30

0.35

6.1

4.6

35.32

35.80

g/l

0.19

188

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

206

1.30

0.35

2.3

2.4

—

(3013512) EKG study

120

1.35

0.35

7.0

4.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

121

1.33

0.33

5.6

3.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.41

0.33

2.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

1.34

0.32

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.29

0.31

4.9

3.2

4.54

6.72

umol/l

—

(36304419) Bacteria [Presence] in Urine

132

1.30

0.30

4.8

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

105

1.31

0.28

5.7

3.4

—

(40768797) Stomach Pathology biopsy report

1.26

0.27

1.8

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1.33

0.27

10.3

3.4

18.60

282.42

ng/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

203

1.23

0.25

6.0

7.7

1.21

1.22

mmol/l

0.08

176

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.24

0.22

18.8

9.2

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

3.4

—

16.00

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.31

0.21

1.3

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

0.00

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

1.8

—

(3044889) 12 lead EKG panel

316

1.21

0.20

4.0

3.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.20

0.0

3.8

—

16.43

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.20

0.0

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

475

1.34

0.18

28.0

15.4

71.57

76.50

umol/l

1.27

475

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.23

0.16

1.9

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.20

0.13

1.6

2.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.18

0.10

2.0

9.8

123.20

121.26

g/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.07

0.10

2.2

1.9

—

(3022145) Colonoscopy Study observation

1.05

0.09

2.4

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

356

1.12

0.09

11.4

7.6

69.41

75.10

u/l

0.93

335

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.79

0.09

1.8

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.79

0.08

1.7

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

142

1.08

0.03

1.7

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

327

0.95

0.01

3.5

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

173

0.97

0.00

4.2

2.0

91.62

101.06

pmol/l

0.51

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

3.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

3.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.8

—

37.35

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

4.0

—

9.86

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

0.91

-0.00

8.8

2.4

46.00

100.04

ug/g

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.1

—

207.51

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

104.20

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

40.56

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.5

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.7

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

17.62

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.5

—

124.00

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

11.06

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.61

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

4.0

—

4.92

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

3.38

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.8

—

89.28

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

0.82

—

(3010421) pH of Blood

0.00

-0.00

0.0

4.1

—

7.44

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PHOTOCONTDERMAT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_PHOTOCONTDERMAT.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_PHOTOCONTDERMAT – Photocontact dermatitis [berloque dermatitis]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Photocontact dermatitis [berloque dermatitis]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints